Matasi, Julius J <br/><br/>
2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs as adenosine A2A antagonists: the successful reduction of hERG activity. Part 2.  [electronic resource] 

 -  Bioorganic & medicinal chemistry letters  Aug 2005 
 - 3675-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0960-894X 
<br/><br/><label>Standard No.: </label>10.1016/j.bmcl.2005.05.043  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine A2 Receptor Antagonists<br/>Administration, Oral<br/>Animals<br/>Catalepsy--drug therapy<br/>Disease Models, Animal<br/>Drug Evaluation, Preclinical<br/>Humans<br/>Molecular Structure<br/>Motor Activity--drug effects<br/>Pyrimidines--chemistry<br/>Rats<br/>Structure-Activity Relationship<br/>Triazoles--chemistry